trending Market Intelligence /marketintelligence/en/news-insights/trending/s8s9iz_zp_rkqzer7dhxdw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Oncobiologics names director

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Oncobiologics names director

Oncobiologics Inc. appointed Joerg Windisch as director, effective March 23.

He was appointed to fill the vacancy created by Yezan Haddadin's resignation from the board, the company said March 27 in an SEC filing.

Windisch is currently COO of Polpharma Biologics.

Cranbury, N.J.-based Oncobiologics is a clinical-stage biopharmaceutical company which focuses on developing biosimilars in immunology and oncology disease areas.